Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, including first evidence of activity in gastric cancer ...
Targeting Initial ‘Stage 1′ DFS & Ore Reserves conversion by H2 CY 2026. HIGHLIGHTS. DFS underway following dual Challenger ...
My name is James Kirby. I cover the industrials equities at JPMorgan. We're really happy to have Columbus McKinnon here. We have CEO, Dave Wilson; CFO, Greg Rustowicz; and Alex Eldredge on the IR team ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results